Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies

ERBB4 is a tyrosine kinase receptor reported to exert both oncogenic and tumor suppressor activities. These paradoxical effects were suggested to stem from different ERBB4 homo-/hetero-dimers and/or isoforms. By stratifying breast cancer patients for clinical and molecular subtypes and ERBB4 mRNA ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Miano, Carmen, Romaniello, Donatella, Mazzeschi, Martina, Morselli, Alessandra, Da Pra, Silvia, Sacchi, Francesca, Bongiovanni, Chiara, Sgarzi, Michela, Pantano, Elvira, Lauriola, Mattia, D’Uva, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157648/
https://www.ncbi.nlm.nih.gov/pubmed/35664762
http://dx.doi.org/10.3389/fonc.2022.831105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157648/
https://www.ncbi.nlm.nih.gov/pubmed/35664762
http://dx.doi.org/10.3389/fonc.2022.831105

Ejemplares similares